Olga Torres

913 total citations
12 papers, 595 citations indexed

About

Olga Torres is a scholar working on Oncology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Olga Torres has authored 12 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Olga Torres's work include Lymphoma Diagnosis and Treatment (5 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Olga Torres is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), HER2/EGFR in Cancer Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Olga Torres collaborates with scholars based in Cuba, United States and Mexico. Olga Torres's co-authors include Rolando Pérez, Tania Crombet, Agustín Lage, Mayra Ramos, I. Leonard, Mauricio Catalá, René Figueredo, Normando Iznaga-Escobar, Eduardo Fernández and Normando Iznaga and has published in prestigious journals such as Journal of Clinical Oncology, Investigative Ophthalmology & Visual Science and International Journal of Infectious Diseases.

In The Last Decade

Olga Torres

12 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olga Torres Cuba	8	374	230	177	140	104	12	595
Mayra Ramos Cuba	16	461 1.2×	297 1.3×	268 1.5×	180 1.3×	112 1.1×	33	827
I. Leonard Cuba	5	354 0.9×	185 0.8×	114 0.6×	156 1.1×	68 0.7×	9	513
Mauricio Catalá Cuba	8	354 0.9×	156 0.7×	155 0.9×	219 1.6×	116 1.1×	16	622
Panteleimon Kountourakis Greece	14	376 1.0×	141 0.6×	75 0.4×	219 1.6×	70 0.7×	32	627
Marta Osorio Cuba	9	304 0.8×	175 0.8×	136 0.8×	250 1.8×	26 0.3×	13	595
Minghuan Li China	14	264 0.7×	275 1.2×	249 1.4×	104 0.7×	21 0.2×	32	614
Khalil Saleh France	12	357 1.0×	137 0.6×	50 0.3×	84 0.6×	39 0.4×	53	523
Claudio Dansky Ullmann United States	14	398 1.1×	136 0.6×	54 0.3×	275 2.0×	39 0.4×	26	797
Kensei Nakata Japan	14	232 0.6×	125 0.5×	72 0.4×	126 0.9×	17 0.2×	30	506
C. Papadimitriou Greece	15	281 0.8×	137 0.6×	61 0.3×	82 0.6×	80 0.8×	30	569

Countries citing papers authored by Olga Torres

Since Specialization

Citations

This map shows the geographic impact of Olga Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Torres more than expected).

Fields of papers citing papers by Olga Torres

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Torres. The network helps show where Olga Torres may publish in the future.

Co-authorship network of co-authors of Olga Torres

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Torres. A scholar is included among the top collaborators of Olga Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Torres. Olga Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Torres, Olga, et al.. (2017). Validation of Instruments for Assessing Drug Safety Management During the Conduction of Clinical Trials. International Journal of Health Policy and Management. 7(7). 623–629. 3 indexed citations

Dueger, Erica, et al.. (2007). Increasing penicillin and trimethoprim–sulfamethoxazole resistance in nasopharyngeal Streptococcus pneumoniae isolates from Guatemalan children, 2001–2006. International Journal of Infectious Diseases. 12(3). 289–297. 8 indexed citations

Crombet, Tania, Mauricio Catalá, Mayra Ramos, et al.. (2006). Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: Report from a phase I/II trial. Cancer Biology & Therapy. 5(4). 375–379. 124 indexed citations

Torres, Luis F., et al.. (2005). Analysis of PCNA, p53, and bcl–2 Expression in the Sequence Primary Acquired Melanosis–Conjunctival Melanoma. Investigative Ophthalmology & Visual Science. 46(13). 3409–3409. 1 indexed citations

Crombet, Tania, Mauricio Catalá, Sara González, et al.. (2005). Treatment of high-grade astrocytic tumors with the humanized anti-EGF-R antibody h-R3 and radiotherapy. Journal of Clinical Oncology. 23(16_suppl). 2554–2554. 5 indexed citations

Crombet, Tania, Marta Osorio, Teresa Cruz, et al.. (2004). Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patients. Journal of Clinical Oncology. 22(9). 1646–1654. 237 indexed citations

Crombet, Tania, Leonel Torres, Elia Neninger, et al.. (2003). Pharmacological Evaluation of Humanized Anti-Epidermal Growth Factor Receptor, Monoclonal Antibody h-R3, in Patients With Advanced Epithelial-Derived Cancer. Journal of Immunotherapy. 26(2). 139–148. 94 indexed citations

Montero, Enrique, Gil Reyes, Olga Torres, et al.. (2002). Immunodiagnosis and therapeutic immunosuppression in rheumatoid arthritis with ior t1 (anti-CD6) monoclonal antibody. Arthritis Research. 4(Suppl 1). 114–114. 7 indexed citations

Crombet, Tania, Olga Torres, Elia Neninger, et al.. (2001). Phase I Clinical Evaluation of a Neutralizing Monoclonal Antibody against Epidermal Growth Factor Receptor. Cancer Biotherapy and Radiopharmaceuticals. 16(1). 93–102. 21 indexed citations

10.

Crombet, Tania, Olga Torres, Vanina Rodríguez, et al.. (2001). Phase I Clinical Evaluation of a Neutralizing Monoclonal Antibody Against Epidermal Growth Factor Receptor in Advanced Brain Tumor Patients: Preliminary Study. Hybridoma. 20(2). 131–136. 49 indexed citations

11.

Ramos, Mayra, Nelson Rodríguez, Normando Iznaga-Escobar, et al.. (1999). 99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy.. PubMed. 40(5). 768–75. 43 indexed citations

12.

Ramos, Mayra, Nelson Rodríguez, Normando Iznaga, et al.. (1999). ior egf/r3: A murine monoclonal antibody for diagnostic of epithelial tumors. Journal of Radioanalytical and Nuclear Chemistry. 240(2). 499–503. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact